Powder
Dried, ground fruiting body powder — the most traditional preparation form.
Powder
One of the Most Important TCM Fungi · 540 Medicinal Mushrooms Recorded
Biological Overview
Ganoderma lucidum is a non-edible Chinese fungus that grows on oaks and plum trees, appearing from June to November on buried wood, exposed roots, or at the base of hardwood or fruit-tree stumps, very rarely on conifers. The cap can reach 15–30 cm across, semi-circular, kidney-shaped and convex, covered with a smooth, glossy, hard, yellow-orange to brown-red and finally almost blackish crust, marked with irregular but well-defined concentric grooves.
FamilyGanodermataceae
Cap DiameterUp to 30 cm
Key CompoundsTriterpenes, Beta-Glucans
CYP3A4 InteractionPotent Inhibitor
Botanical Classification
Taxonomy & Identification
- Latin Name
- Ganoderma lucidum (Fr.) P. Krast.
- Family
- Ganodermataceae
- Common Names
- Lingzhi, Reishi, Ganoderme luisant, Polypore livide
- Parts Used
- Aerial part (fruiting body)
- Origin
- China & other Asian countries
- Habitat
- Hardwood/fruit tree stumps, rare on conifers
Ethnobotany & Traditional Use
History & Tradition
Ganoderma lucidum is produced in China and other Asian countries, and has been used in traditional medicine to prevent and treat a wide range of human illnesses, particularly in China, Japan and Korea.
It is one of the most important mushrooms used by Traditional Chinese Medicine, among 540 medicinal mushrooms recorded. [1]
The Key Compounds
Triterpenes & Polysaccharides — Deep Dive
Two distinct compound classes anchor nearly every documented effect — and together explain why Reishi is both pharmacologically active and pharmacologically risky to combine with other drugs.
🛡️
🧬
Antitumor Triterpenes
Hyperoxidized triterpenes bonded to C30 molecules and lanostanes — including ganoderic, ganolucidic and lucidenic acids — inhibit hepatic tumor cell growth without affecting normal hepatocytes and induce apoptosis in liver, spleen, breast and prostate cancer cells. [20]
🧪
CYP3A4 & CYP2E1 Modulation
Ganoderma polysaccharides significantly affect CYP2E1, CYP1A2 and CYP3A activities in hepatic tissue — the documented mechanism behind Reishi's serious drug-interaction profile. [14]
🌳
Beta-Glucan Dendritic Cell Activation
The beta-glucan fraction activates dendritic cells to produce larger quantities of IL-23, inducing Th17 cell differentiation. [11]
Available Preparations
Parts Used & Available Forms
The aerial part (fruiting body) is the sole part used, available as powder, dry extract or fluid extract.
Standardized Dry Extract
Aqueous dry extract, typically standardized to polysaccharide content — the form used in the source's own usual dosage guidance.
Dry Extract · Standardized
Fluid Extract
Liquid extract preparation, used in traditional phytotherapeutic practice.
Fluid Extract
Clinical Dosimetry
Dosages
The primary source gives one specific, standardized usual dose.
Phytochemistry
Composition
Documented composition of the fungus, the sole category with described components in the primary source.
PolysaccharidesBranched (1→6)-beta-D-glucan, acidic and neutral beta-D-glucan fractions, of highly variable molecular weight
Key Compound
GlycoproteinsDocumented glycoprotein fraction
Present
HeteroglucidesD-mannose, D-glucuronic acid
Present
TriterpenesHyperoxidized triterpenes bonded to C30 molecules and lanostanes: ganoderic, ganolucidic and lucidenic acids, ganodermic acids, ganodermanotriol
Key Compound
D-XyloseDocumented sugar component
Present
SterolsErgosterol (provitamin D2), steroids, 7-beta-hydroxy-sterols
Present
Other ComponentsAdenosine, nucleosides, lysine, fatty acids, alkaloids
Present
🛡️
Immunostimulant
Polysaccharides increase TNF-alpha secretion and favor helper T-cell immune response. [3][6]
🦠
Broad Immunomodulation
Induces phagocytosis, antigen-presenting cell function, and both humoral and cellular immunity; aqueous extract increases immunocompetent tissue weight, macrophage phagocytosis, T-lymphocyte proliferation and NK activity, especially in immunosuppressed mice. [7][8]
🧬
M1 Macrophage Activation
Activates M1 macrophages producing more TNF-α, IL-6 and IL-12; increases NO and iNOS activity along with peritoneal macrophage phagocytic activity. [9][10]
🌳
Dendritic Cell & Th17 Induction
Beta-glucan activates dendritic cells to produce IL-23 and induces Th17 cell differentiation. [11]
🩹
Intestinal Immune Support
Increases IgA and the alpha-defensins RD-5 and RD-6, broad-spectrum antimicrobial peptides. [12]
🧬
Antimutagenic
Documented antimutagenic activity. [13]
🛡️
Hepatoprotective
Prevents elevation of transaminases and alkaline phosphatase. [14]
🧪
Antioxidant
Increases reduced glutathione concentrations and glutathione peroxidase, glutathione-S-transferase and superoxide dismutase activities.
🩹
Gastroprotective
Documented gastroprotective activity against experimental lesions. [15]
🧠
Neuroprotective
Supports and regenerates the neuronal transmission network, anti-inflammatory and protective for microglia, with potential relevance to Parkinson's disease. [16][18]
😊
Probable Antidepressant Properties
A water-soluble extract from Ganoderma lucidum mycelial culture medium shows antidepressant-like effects in rats. [19]
🎗️
Antitumor (Triterpenes & Polysaccharides)
Inhibits hepatic tumor cell growth without affecting normal hepatocytes, induces apoptosis in liver, spleen, breast and prostate cancers, through host immune activation, cell differentiation induction, phase II enzyme induction, and angiogenesis inhibition. [20][24][25]
🫀
Antihypertensive & Hypocholesterolemic
Antihypertensive activity via angiotensin-converting enzyme, and documented hypocholesterolemic effect. [46][47]
🦠
Antiviral
Reduces genital and labial herpes recurrences, documented anti-HIV activity, and inhibits dengue virus protease via ganodermanotriol. [48][49][50]
Clinical Applications
Clinical Indications
Traditional and researched uses for the whole plant, including two the primary source itself flags as uncertain.
💪
General & Immune
Asthenia & Infectious States
- Physical & psychological asthenia: documented traditional indication.
- States requiring immunostimulation: documented indication (infectiology).
- Allergic conditions: documented traditional indication.
🦴
Pain & Muscle
Myopathies
- Pain & myopathies: myotonia and myodystrophy with muscle spasms.
🫀
Cardiometabolic
Hypertension & Metabolic States
- Hypertension, arteritis, heart failure: documented indications.
- Plethoric states, hyperlipemia, diabetes: documented indications.
❔
Investigational
Flagged Uncertain in Primary Source
- Parkinson's disease: explicitly marked as uncertain ("?") in the primary source itself. [18]
- AIDS: also marked as uncertain ("?") — a preliminary, not established, indication.
🧠
Neurological
Central Nervous System
- Central neurological disorders of diverse etiologies: documented traditional indication.
Pharmacodynamics
Mode of Action
The documented mechanisms behind Reishi's immunomodulant, hepatoprotective and antioxidant activity.
🛡️
TNF-Alpha Secretion & T-Helper Response
Increases TNF-alpha secretion and favors the helper T-cell immune response.
🧬
Marked Antimutagenic Activity
Documented antimutagenic activity, per the primary source's own mode-of-action summary. [13]
🫁
Hepatoprotection
Prevents elevation of transaminases and alkaline phosphatase. [14]
🧪
Antioxidant Enzyme Induction
Increases reduced glutathione concentrations and the activities of glutathione peroxidase, glutathione-S-transferase and superoxide dismutase.
Clinical Safety
Safety, Interactions & Precautions
Reishi carries a genuinely serious risk profile, especially for cancer patients on targeted therapy and transplant recipients — this section should be read in full before use.
⚠ Absolute Contraindications
Do Not Combine or Use in These Situations
- Targeted cancer therapies & tyrosine kinase inhibitors: Reishi is a potent CYP3A4 inhibitor, documented as incompatible with targeted therapies and all protein-tyrosine kinase inhibitors, which can raise their plasma concentrations. [59][60]
- Transplant recipients & immunosuppressant therapy: do not use, per the primary source's explicit instruction.
- Anticoagulants: avoid concurrent use.
- Pregnancy & breastfeeding: avoid, per the primary source.
General Tolerability
- Trial context: a randomized, double-blind, placebo-controlled study of Lingzhi's immunomodulatory effects in children with cancer documented its use in a closely monitored clinical setting. [58]
- No broader adverse-effect catalog documented: the primary source's own safety section focuses specifically on the four contraindications above, rather than a wider list of mild adverse effects.
Mechanism Behind the Interactions
- Hepatic CYP modulation: Ganoderma polysaccharides significantly affect CYP2E1, CYP1A2 and CYP3A activities in the liver — the documented basis for the interaction risk with targeted cancer therapies. [14]
Clinical Disclaimer: This monograph is for educational and professional reference only. It does not constitute medical advice, diagnosis, or treatment guidance. Reishi carries documented, serious risks, especially for people undergoing targeted cancer therapy, organ transplant recipients, and those on immunosuppressants or anticoagulants. Always consult a qualified healthcare provider before use.
Common Questions
Frequently Asked Questions
What is Reishi (Lingzhi) traditionally used for?
Ganoderma lucidum is one of the most important mushrooms used in Traditional Chinese Medicine, among 540 medicinal mushrooms recorded, used to prevent and treat various human illnesses, particularly in China, Japan and Korea.
Which part of the mushroom is used medicinally?
The aerial part (the fruiting body) is the part used.
What are the key compounds in Reishi?
Triterpenes — hyperoxidized compounds including ganoderic, ganolucidic and lucidenic acids — and polysaccharides, chiefly branched (1→6)-beta-D-glucan and other beta-D-glucan fractions, are the two main compound classes behind most of Reishi's documented pharmacological activity.
Does Reishi actually help fight cancer?
There is extensive preclinical and mechanistic evidence: apoptosis induction in liver, spleen, breast and prostate cancer cells, host immune activation, anti-angiogenic activity, and inhibition of cancer cell invasion and metastasis genes. A Cochrane review evaluated Ganoderma lucidum as a potential adjuvant alongside conventional cancer treatment, not as a standalone treatment.
Can Reishi be taken alongside cancer drugs?
No, not without direct medical supervision. Reishi is a potent inhibitor of the CYP3A4 enzyme and is documented as incompatible with targeted cancer therapies and all protein-tyrosine kinase inhibitors, as it can increase their plasma levels to potentially dangerous concentrations.
Who should absolutely avoid Reishi?
The primary source is explicit: Reishi should not be used by transplant recipients or people on immunosuppressant therapy, should not be combined with anticoagulants, and should be avoided during pregnancy or breastfeeding.
Does Reishi help with sleep or stress?
Reishi is traditionally indicated for physical and psychological asthenia, and animal research has documented probable antidepressant-like effects from a water-soluble mycelial culture extract. However, the primary source does not include a dedicated human sleep trial, so this remains a traditional and mechanistic indication rather than one confirmed by dedicated clinical trials.
Is Reishi proven to help with Parkinson's disease or AIDS?
No, both are explicitly flagged as uncertain, marked with a question mark, in the primary phytotherapy source itself — preliminary, mechanistically plausible research areas, not established indications.
Primary Literature
Bibliography
↑1. Dai YC, Yang ZL, Cui BK, Yu CJ, Zhou LW. Species Diversity and Utilization of Medicinal Mushrooms and Fungi in China (Review). Int J Med Mushrooms. 2009;11:287-302. DOI: 10.1615/IntJMedMushr.v11.i3.80 →
↑2. Galappaththi MCA, Patabendige NM, Premarathne BM, Hapuarachchi KK, Tibpromma S, Dai DQ, Suwannarach N, Rapior S, Karunarathna SC. A Review of Ganoderma Triterpenoids and Their Bioactivities. Biomolecules. 2022 Dec 22;13(1):24. PubMed PMID:36671409 →
↑3. Lin YL, Lee SS, Hou SM, Chiang BL. Polysaccharide purified from Ganoderma lucidum induced gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice. Mol Pharmacol. 2006 Aug;70(2):637-44.
↑4. Chen HS, Tsai YF, Lin S, Lin CC, Khoo KH, Lin CH, Wong CH. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem. 2004 Nov 1;12(21):5595-601.
↑5. Xu Z, Chen X, Zhong Z, Chen L, Wang Y. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 2011;39(1):15-27. PubMed PMID:21213395 →
↑6. Yue GGL, Fung KP, Leung PC, Lau CBS. Comparative Studies on the Immunomodulatory and Antitumor Activities of the Different Parts of Fruiting Body of Ganoderma lucidum and Ganoderma Spores. Phytother Res. 2008;22:1282-1291.
↑7. Lin ZB. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci. 2005 Oct;99(2):144-53. PubMed PMID:16230843 →
↑8. Wang K, Wu G, Dai S. Study on the immunological effect of the aqueous extract from Guangxi Ganoderma lucidum in mice. J Guangxi Med Univ. 2003-06.
↑9. Sun LX, Lin ZB, Lu J, Li WD, Niu YD, Sun Y, Hu CY, Zhang GQ, Duan XS. The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum. Immunol Res. 2017 Jun;65(3):658-665. PubMed PMID:28124732 →
↑10. Liu Z, Xing J, Huang Y, Bo R, Zheng S, Luo L, Niu Y, Zhang Y, Hu Y, Liu J, Wu Y, Wang D. Activation effect of Ganoderma lucidum polysaccharides liposomes on murine peritoneal macrophages. Int J Biol Macromol. 2016 Jan;82:973-8. PubMed PMID:26529190 →
↑11. Yoshida H, Suzuki M, Sakaguchi R, Tani I, Kotani H, Shudo N, Yoshimura A. Preferential induction of Th17 cells in vitro and in vivo by Fucogalactan from Ganoderma lucidum (Reishi). Biochem Biophys Res Commun. 2012;422(1):174-180.
↑12. Kubota A, Kobayashi M, Sarashina S, Takeno R, Okamoto K, Narumi K, Furugen A, Suzuki Y, Takahashi N, Iseki K. Reishi mushroom Ganoderma lucidum modulates IgA production and alpha-defensin expression in the rat small intestine. J Ethnopharmacol. 2018 Mar 25;214:240-243. PubMed PMID:29248453 →
↑13. Lakshmi B, Ajith TA, Jose N, Janardhanan KK. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. J Ethnopharmacol. 2006 Sep 19;107(2):297-303.
↑14. Wang X, Zhao X, Li D, Lou YQ, Lin ZB, Zhang GL. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharm Bull. 2007;30(9):1702-1706. PubMed PMID:17827724 →
↑15. Gao Y, Zhou S, Wen J, Huang M, Xu A. Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci. 2002 Dec 27;72(6):731-45. PubMed PMID:12467913 →
↑16. Phan C, David P, Naidu M, Wong K, Sabaratnam V. Neurite outgrowth stimulatory effects of culinary-medicinal mushrooms and their toxicity assessment using differentiating Neuro-2a and embryonic fibroblast BALB/3T3. BMC Complement Altern Med. 2013;13:261. Abstract →
↑17. Ling-Sing Seow S, Naidu M, David P, Wong K, Sabaratnam V. Potentiation of neuritogenic activity of medicinal mushrooms in rat pheochromocytoma cells. BMC Complement Altern Med. 2013;13:157. Abstract →
↑18. Zhang R, Xu S, Cai Y, Zhou M, Zuo X, Chan P. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation. Evid Based Complement Alternat Med. 2011;2011:156810. PubMed PMID:19617199 →
↑19. Matsuzaki H, Shimizu Y, Iwata N, Kamiuchi S, Suzuki F, Iizuka H, Hibino Y, Okazaki M. Antidepressant-like effects of a water-soluble extract from the culture medium of Ganoderma lucidum mycelia in rats. BMC Complement Altern Med. 2013;13:370. Abstract →
↑20. Patel S, Goyal A. Recent developments in mushrooms as anti-cancer therapeutics: a review. 3 Biotech. 2012 Mar;2(1):1-15. PubMed PMID:22582152 →
↑21. Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2012 Jun 13;6:CD007731. PubMed PMID:22696372 →
↑22. Wasser SP. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74. PubMed PMID:12436306 →
↑23. Kimura Y. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo. 2005 Jan-Feb;19(1):37-60. PubMed PMID:15796155 →
↑24. Liu GQ, Zhang KC. Mechanisms of the Anticancer Action of Ganoderma lucidum (Leyss. ex Fr.) Karst.: A New Understanding. J Integr Plant Biol. 2005;47:129-135. DOI: 10.1111/j.1744-7909.2005.00037.x →
↑25. Xu Z, Chen X, Zhong Z, Chen L, Wang Y. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 2011;39(1):15-27. PubMed PMID:21213395 →
↑26. Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer. 2004;49(2):209-16.
↑27. Gonul O, Aydin HH, Kalmis E, Kayalar H, Ozkaya AB, Atay S, Ak H. Effects of Ganoderma lucidum Extracts on the miRNA Profile and Telomerase Activity of the MCF-7 Breast Cancer Cell Line. Int J Med Mushrooms. 2015;17(3):231-9. PubMed PMID:25954907 →
↑28. Hu H, Ahn NS, Yang X, Lee YS, Kang KS. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer. 2002;102(3):250-253. PubMed PMID:12397644 →
↑29. Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, Schneider RJ, Martínez-Montemayor MM. Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. PLoS One. 2013;8(2):e57431. PubMed PMID:23468988 →
↑30. Liu RM, Li YB, Zhong JJ. Cytotoxic and pro-apoptotic effects of novel ganoderic acid derivatives on human cervical cancer cells in vitro. Eur J Pharmacol. 2012 Apr 15;681(1-3):23-33. PubMed PMID:22366428 →
↑31. Ye T, Ge Y, Jiang X, Song H, Peng C, Liu B. A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer. Chin Med. 2023 Aug 28;18(1):107. PubMed PMID:37641070 →
↑32. Loganathan J, Jiang J, Smith A, Jedinak A, Thyagarajan-Sahu A, Sandusky GE, Nakshatri H, Sliva D. The mushroom Ganoderma lucidum suppresses breast-to-lung cancer metastasis through the inhibition of pro-invasive genes. Int J Oncol. 2014 Jun;44(6):2009-15. PubMed PMID:24718855 →
↑33. Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol. 2004 May;24(5):1093-9. PubMed PMID:15067330 →
↑34. Zaidman BZ, Wasser SP, Nevo E, Mahajna J. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Int J Oncol. 2007 Oct;31(4):959-67. PubMed PMID:17786330 →
↑35. Zhao X, Zhou D, Liu Y, Li C, Zhao X, Li Y, Li W. Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway. Mol Med Rep. 2018;17(1):147-157.
↑36. Nahata A, Dixit VK. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats. Andrologia. 2012 May;44 Suppl 1:160-74. PubMed PMID:21651601 →
↑37. Liu J, Kurashiki K, Shimizu K, Kondo R. Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum. Bioorg Med Chem. 2006 Dec 15;14(24):8654-60. PubMed PMID:16962782 →
↑38. Liu J, Tamura S, Kurashiki K, Shimizu K, Noda K, Konishi F, Kumamoto S, Kondo R. Anti-androgen effects of extracts and compounds from Ganoderma lucidum. Chem Biodivers. 2009 Feb;6(2):231-43. PubMed PMID:19235153 →
↑39. Liu J, Shimizu K, Konishi F, Kumamoto S, Kondo R. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Bioorg Med Chem. 2007 Jul 15;15(14):4966-72. PubMed PMID:17499997 →
↑40. Fujita R, Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Ueda C, Tajiri H, Kaneko S, Suimi Y, Kondo R. Anti-androgenic activities of Ganoderma lucidum. J Ethnopharmacol. 2005 Oct 31;102(1):107-12. PubMed PMID:16029938 →
↑41. Zheng S, Jia Y, Zhao J, Wei Q, Liu Y. Ganoderma lucidum polysaccharides eradicates the blocking effect of fibrinogen on NK cytotoxicity against melanoma cells. Oncol Lett. 2012 Mar;3(3):613-616. PubMed PMID:22740961 →
↑42. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003 Aug;32(3):201-15. PubMed PMID:12916709 →
↑43. Weng CJ, Yen GC. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis. 2010 May;27(5):361-9. PubMed PMID:20461449 →
↑44. Zhao S, Ye G, Fu G, Cheng JX, Yang BB, Peng C. Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol. 2011 May;38(5):1319-27. PubMed PMID:21399867 →
↑45. Ma L, Chen H, Dong P, Lu X. Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus. Food Chem. 2013 Aug 15;139(1-4):503-8. PubMed PMID:23561137 →
↑46. Mohamad Ansor N, Abdullah N, Aminudin N. Anti-angiotensin converting enzyme (ACE) proteins from mycelia of Ganoderma lucidum (Curtis) P. Karst. BMC Complement Altern Med. 2013 Oct 4;13(1):256. PubMed PMID:24093919 →
↑47. Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T, Li J. Reishi, Ganoderma lucidum and Ganoderma tsugae: Bioactive substances and medicinal effects. Food Rev Int. 1995;11(1):151-166. Abstract →
↑48. Hijikata Y, Yamada S, Yasuhara A. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis. J Altern Complement Med. 2007 Nov;13(9):985-7. PubMed PMID:18047445 →
↑49. El-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N, Shimotohno K, Kawahata T, Otake T. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998;49(6):1651-1657.
↑50. Islam MT, Quispe C, Herrera-Bravo J, Sarkar C, Sharma R, Garg N, Fredes LI, Martorell M, Alshehri MM, Sharifi-Rad J, Daştan SD, Calina D, Alsafi R, Alghamdi S, Batiha GE, Cruz-Martins N. Production, Transmission, Pathogenesis, and Control of Dengue Virus: A Literature-Based Undivided Perspective. Biomed Res Int. 2021 Dec 15;2021:4224816. PubMed PMID:34957305 →
↑51. Bharadwaj S, Lee KE, Dwivedi VD, Yadava U, Panwar A, Lucas SJ, Pandey A, Kang SG. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease. Sci Rep. 2019 Dec 13;9(1):19059. PubMed PMID:31836806 →
↑52. Ogbeide OK, Aghedo ON, Uadia JO. Anti-inflammatory and Analgesic Investigations of Methanol Extract of Ganoderma lucidum. Trop J Phytochem Pharm Sci. 2022;1(1):17-22. Full Text →
↑53. Chen X, Veena RK, Ramya H, Janardhanan KK, George V. Gano oil: A novel antinociceptive agent extracted from Ganoderma lucidum inhibits paw oedema and relieves pain by hypnotic and analgesic actions of fatty acid amides. J Ethnopharmacol. 2020;263:113144. DOI: 10.1016/j.jep.2020.113144 →
↑54. Rezaei K, Sheikholeslami M, Salimi-Sabour E, Lotfali E, Parvardeh S. Attenuation of Morphine Dependence by Ganoderma lucidum Extract in Mice. Jundishapur J Nat Pharm Prod. 2022;17(4):e123164. DOI: 10.5812/jjnpp-123164 →
↑55. Goetz P. Adapter les adaptogènes : Revue du concept de drogue végétale adaptogène. Phytothérapie. 2002;18.
↑56. Oke MA, Afolabi FJ, Oyeleke OO, Kilani TA, Adeosun AR, Olanbiwoninu AA, Adebayo EA. Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa. Front Pharmacol. 2022 Aug 22;13:952027. PubMed PMID:36071846 →
↑57. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther. 2003 Dec;2(4):358-64. PubMed PMID:14713328 →
↑58. Shing M, Leung TF, Chu Y, Li C, Chik K, Leung P, Lee V, Yuen P, Li C. Randomized, double-blind and placebo-controlled study of the immunomodulatory effects of Lingzhi in children with cancers. J Clin Oncol. 2008;26:14021.
↑59. Wang X, Zhao X, Li D, Lou YQ, Lin ZB, Zhang GL. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharm Bull. 2007;30(9):1702-1706. PubMed PMID:17827724 →